A randomized trial of efficacy of beta-sitosterol and its glucoside as adjuvant to cryotherapy in the treatment of anogenital warts

References

• Cates W. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999;26:S2–7
   PubMed Web of Science ®Google Scholar
• Wiley DJ, Douglas J, Beutner K, et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. 2002;35:S210–24
   PubMed Web of Science ®Google Scholar
• Stefanaki C, Katzouranis I, Lagogianni E, et al. Comparison of cryotherapy to imiquimod 5% in the treatment of anogenital warts. Int J STD AIDS. 2008;19:441–4
   Google Scholar
• Beutner KR, Spruance SL, Hougham AJ, et al. Treatment of genital warts with an immune response modifier (imiquimod). J Am Acad Dermatol. 1998;38:230–9
   PubMed Web of Science ®Google Scholar
• Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol. 1998;134:25–30
   PubMed Web of Science ®Google Scholar
• Kaspari M, Gutzmer R, Kaspari T, et al. Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma. Br J Dermatol. 2002;147:757–9
   PubMed Web of Science ®Google Scholar
• Hemmi H, Kaisho T, Takekuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3:196–200
   PubMed Web of Science ®Google Scholar
• Tyring SK, Arany I, Stanley MA, et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis. 1998;78:551–5
   Google Scholar
• Breytenbach U, Clark A, Lambrecht J, Bouic P. Flow cytometric analysis of the TH1-TH2 balance in healthy individuals and patients infected with the human immunodeficiency virus (HIV) receiving a plant sterol/sterolin mixture. Cell Biol Int. 2001;25:43–9
   PubMedGoogle Scholar
• Bouic P. Sterols and sterolins: new drugs for the immune system? Drug Discov Today. 2002;7:775–8
   PubMed Web of Science ®Google Scholar
• Bouic PJD, Etsebeth S, Liebenberg RW, et al. Beta-sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: implications for their use as an immunomodulatory vitamin combination. Int J Immunopharmacol. 1996;18:693–700
   PubMed Web of Science ®Google Scholar
• Bouic PJD, Lamprecht J. Plant sterols and sterolins: a review of their immune-modulating properties. Alt Med Rev. 1999;4:170–7
   PubMedGoogle Scholar
• Collett D. Modelling Survival Data in Medical Research, 2nd ed. Boca Raton, FA: Chapman and Hall/CRC
   Google Scholar
• Pollak OJ. Effect of plant sterols on serum lipids and atherosclerosis. Pharmacol Ther. 1985;31:177–208
   PubMed Web of Science ®Google Scholar
• Pegel RH, The importance of sitosterol and sitosterolins in human and animal nutrition. S Afr J Sci. 1997;93:263–8
   Web of Science ®Google Scholar
• Lacey CJN. Therapy for genital human papillomavirus-related disease. J Clin Virol. 2005;328:S82–90
   Google Scholar
• Coleman N, Birley HDL, Renton AM, et al. Immunological events in regressing genital warts. Am J Clin Pathol. 1994;102:768–74
   PubMed Web of Science ®Google Scholar
• Gunter J. Genital and perianal warts: new treatment opportunities for human papillomavirus infection. Am J Obstet Gynecol. 2003;189:S3–11
   PubMed Web of Science ®Google Scholar
• Tyring SR. Human papillomavirus infections: epidemiology, pathogenesis and host immune response. J Am Acad Dermatol. 2000;43:S18–26
   Google Scholar
• Altmann A, Jochmus I, Rosl F. Intra- and extracellular control mechanisms of human papillomavirus infections. Intervirology. 1994;37:180–8
   Google Scholar
• Arany I, Rady P, Tyring SR. Alterations in cytokine/antioncogene expression in the skin lesions caused by low-risk types of human papillomavirus. Viral Immunol. 1993;6:255–65
   Google Scholar
• Bouic P, Lambrecht JH, Freestone M, et al. Plant sterol and sterolin supplement use in a cohort of SA HIV-infected patients: effects on immunological and virological surrogate markers. S Afr Med J. 2001;91:848–50
   PubMed Web of Science ®Google Scholar
• Abdullah AN, Walzman M, Wade A. Treatment of external genital warts comparing cryotherapy and trichloacetic acid. Sex Transm Dis. 1993;20:344–5
   PubMedGoogle Scholar
• Godley MJ, Bradbeer CS, Gellan M, Thin RNT. Cryotherapy compared with trichloroacetic acid in treating genital warts. Genitourin Med. 1987;63:390–2
   PubMedGoogle Scholar
• Stone K, Becker T, Hagdu A, Kraus S. Treatment of external genital warts: a randomized clinical trial comparing podophyllin, cryotherapy, and electrodessication. Genitourin Med. 1990;66:16–19
   PubMedGoogle Scholar
• Maw R. Critical appraisal of commonly used treatment for genital warts. Int J STD & AIDS. 2004;15:357–64
   Google Scholar
• Donald PR, Lamprecht JH, Freestone M, et al. A randomized placebo-controlled trial of the efficacy of beta-sitosterol and its glucoside as adjuvants in the treatment of pulmonary tuberculosis. Int J Tuberc Lung Dis. 1997;1:518–22
   PubMed Web of Science ®Google Scholar
• Bouic PJD, Clark A, Lamprecht JH, et al. The effects of b-sitosterol (BSS) and b-sitisterol glucoside (BSSG) mixture on selected immune parameters of marathon runners: inhibition of post marathon immune suppression and inflammation. Int J Sports Med. 1999;20:258–62
   PubMed Web of Science ®Google Scholar
• Tying S, Edwards L, Cherry K, et al. Safety and efficacy of 0.5% podophyllox gel in the treatment of anogenital warts. Arch Dermatol. 1998;134:33–8
   Google Scholar